| |
| |
|
| Insider
Information: |
Luthringer Remy |
| Relationship: |
CEO, Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
68,994 |
|
|
Indirect Shares
|
115,825 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
184,819 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Minerva Neurosciences, Inc. |
NERV |
CEO, Director |
2023-05-02 |
68,994 |
2023-05-02 |
115,825 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2023-05-02 |
4 |
S |
$3.76 |
$13,690 |
D/D |
(3,641) |
68,994 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2023-05-01 |
4 |
S |
$3.85 |
$91,449 |
D/D |
(23,753) |
72,635 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2023-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
88,077 |
96,388 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2020-12-16 |
4 |
S |
$2.64 |
$3,432 |
D/D |
(1,300) |
66,490 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2020-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
67,790 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2019-12-17 |
4 |
S |
$7.10 |
$17,125 |
D/D |
(2,412) |
49,040 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2019-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
51,452 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2018-12-17 |
4 |
S |
$7.46 |
$19,426 |
D/D |
(2,604) |
32,702 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2018-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
35,306 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2017-12-14 |
4 |
S |
$5.85 |
$12,835 |
D/D |
(2,194) |
16,556 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
CEO |
• • – |
2017-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
18,750 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
President & CEO |
• • – |
2017-02-06 |
4 |
AS |
$11.00 |
$24,035 |
D/D |
(2,185) |
0 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
President & CEO |
• • – |
2017-02-06 |
4 |
OE |
$4.71 |
$10,291 |
D/D |
2,185 |
2,185 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
President & CEO |
• • – |
2017-02-03 |
4 |
AS |
$11.02 |
$353,698 |
D/D |
(32,096) |
0 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
President & CEO |
• • – |
2017-02-03 |
4 |
OE |
$4.71 |
$151,172 |
D/D |
32,096 |
32,096 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
EVP and Head of R&DOfficer |
• – – |
2014-06-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
926,604 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
